Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.

Ahlem CN, Frincke JM, White SK, Reading CL, Trauger RJ, Lakshmanaswamy R.

Int J Breast Cancer. 2011;2011:618757. doi: 10.4061/2011/618757. Epub 2011 Feb 14.

2.

Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235).

Trauger R, Corey E, Bell D, White S, Garsd A, Stickney D, Reading C, Frincke J.

Br J Cancer. 2009 Apr 7;100(7):1068-72. doi: 10.1038/sj.bjc.6604987.

3.

Configurational analysis and relative binding affinities of 16-methyl-5alpha-androstane derivatives.

Tapolcsányi P, Wölfling J, Tóth I, Szécsi M, Forgó P, Schneider G.

Steroids. 2001 Nov;66(11):833-43.

PMID:
11576623
4.

Assessment of steroidogenesis and steroidogenic enzyme functions.

Luu-The V.

J Steroid Biochem Mol Biol. 2013 Sep;137:176-82. doi: 10.1016/j.jsbmb.2013.05.017. Epub 2013 Jun 13. Review.

PMID:
23770321
6.

Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.

Pérez-Palacios G, Santillán R, García-Becerra R, Borja-Cacho E, Larrea F, Damián-Matsumura P, González L, Lemus AE.

J Endocrinol. 2006 Sep;190(3):805-18.

7.

A neuroactive steroid 5alpha-androstane-3alpha,17beta-diol regulates androgen receptor level in astrocytes.

Agapova OA, Malone PE, Hernandez MR.

J Neurochem. 2006 Jul;98(2):355-63. Epub 2006 Apr 21.

8.

Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?

Kalogera E, Pistos C, Provatopoulou X, Athanaselis S, Spiliopoulou C, Gounaris A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 1;940:24-34. doi: 10.1016/j.jchromb.2013.09.022. Epub 2013 Sep 27. Review.

PMID:
24140653
9.
10.

Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.

Nunlist EH, Dozmorov I, Tang Y, Cowan R, Centola M, Lin HK.

J Steroid Biochem Mol Biol. 2004 Jul;91(3):157-70.

PMID:
15276623
11.

Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.

Chen J, Wang WQ, Lin SX.

J Steroid Biochem Mol Biol. 2013 Sep;137:316-21. doi: 10.1016/j.jsbmb.2013.01.012. Epub 2013 Feb 14.

PMID:
23416106
12.
13.
15.

17α-alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.

Ahlem C, Kennedy M, Page T, Bell D, Delorme E, Villegas S, Reading C, White S, Stickney D, Frincke J.

Invest New Drugs. 2012 Feb;30(1):59-78. doi: 10.1007/s10637-010-9517-0. Epub 2010 Sep 3.

PMID:
20814732
16.

The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta.

Norata GD, Cattaneo P, Poletti A, Catapano AL.

Atherosclerosis. 2010 Sep;212(1):100-6. doi: 10.1016/j.atherosclerosis.2010.05.015. Epub 2010 May 19.

PMID:
20557886
17.

The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay.

Laband P, Tresguerres JA, Lisboa BP, Volkwein U, Tamm J.

Acta Endocrinol (Copenh). 1978 Aug;88(4):778-86.

PMID:
581118
18.

Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.

Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V, Tchernof A.

J Endocrinol. 2006 Dec;191(3):637-49.

19.

5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.

Zimmerman RA, Dozmorov I, Nunlist EH, Tang Y, Li X, Cowan R, Centola M, Frank MB, Culkin DJ, Lin HK.

Prostate Cancer Prostatic Dis. 2004;7(4):364-74.

PMID:
15452555

Supplemental Content

Support Center